Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    9836012 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia
Condition: Schizophrenia
Intervention: Dietary Supplement: Sarcosine
2 Unknown  D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: D-serine;   Behavioral: Cognitive retraining
3 Completed D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: D-serine;   Behavioral: Cognitive retraining
4 Enrolling by invitation Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
Conditions: Schizophrenia;   Bipolar Disorder
Interventions: Drug: D-cycloserine;   Drug: placebo
5 Enrolling by invitation Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
Conditions: Schizo-affective Disorder;   Bipolar Disorder
Interventions: Drug: glycine powder;   Drug: placebo

Indicates status has not been verified in more than two years